Background and Objectives: Trachelectomy, a fertility-sparing surgery for early-stage cervical cancer, can be performed only when there is no extrauterine extension present. Therefore, identifying the sentinel lymph nodes (SLNs) and using them to obtain an intraoperative pathologic diagnosis can provide information on the feasibility and safety of trachelectomy. Our aim was to assess the value of an intraoperative SLN diagnosis. Methods: We retrospectively analyzed the accuracy of intraoperative imprint cytology and frozen-section examination in 201 patients at our institution in whom trachelectomy was planned. Results: All patients could be evaluated for SLNs; a total of 610 SLNs were analyzed. Although the specificity of both imprint cytology and frozen-section examination was 100.0%, the sensitivity was only 58.6 and 65.5%, respectively. The diagnostic sensitivity was higher in 2-mm slices along the short axis than on bisection along the longitudinal axis. Imprint cytology correctly diagnosed 2 patients who had false-negative results on frozen section. The nature of the metastatic foci that caused an intraoperative false-negative diagnosis was either micrometastasis or isolated tumor cells. Conclusions: The accuracy of intraoperative SLN diagnosis requires improvement, especially when small metastatic foci are present.

Keywords:
Uterine cervical neoplasms, Trachelectomy, Sentinel lymph node, Neoplasm metastasis
1.
World Health Organization International Agency for Research on Cancer: Cervical Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (accessed September 17, 2017).
2.
National Cancer Center, Japan; Center for Cancer Control and Information Services: Cancer Incidence (in Japanese). http://ganjoho.jp/reg_stat/statistics/dl/index.html (accessed September 17, 2017).
3.
Lynge E, Rygaard C, Baillet MV, Dugué PA, Sander BB, Bonde J, Rebolj M: Cervical cancer screening at crossroads. APMIS 2014;122:667-673.
4.
Narayan K, Lin MY: Staging for cervix cancer: role of radiology, surgery and clinical assessment. Best Pract Res Clin Obstet Gynaecol 2015;29:833-844.
5.
Rob L, Skapa P, Robova H: Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol 2011;12:192-200.
6.
Dargent D, Martin X, Sacchetoni A, Mathevet P: Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer 2000;88:1877-1882.
7.
Smith JR, Boyle DC, Corless DJ, Ungar L, Lawson AD, Del Priore G, McCall JM, Lindsay I, Bridges JE: Abdominal radical trachelectomy: a new surgical technique for the conservative management of cervical carcinoma. Br J Obstet Gynecol 1997;104:1196-1200.
8.
Okugawa K, Kobayashi H, Sonoda K, Kaneki E, Kawano Y, Hidaka N, Egashira K, Fujita Y, Yahata H, Kato K: Oncologic and obstetric outcomes and complications during pregnancy after fertility-sparing abdominal trachelectomy for cervical cancer: a retrospective review. Int J Clin Oncol 2017;22:340-346.
9.
Sonoda K, Kobayashi H, Wake N: Cervical carcinoma surveillance counterpoint: Japan; in Johnson FE, Maehara Y, Browman GP, Margenthaler JA, Audisio RA, Thompson JF, Johnson DY, Earle CC, Virgo KS (eds): Patient Surveillance after Cancer Treatment. New York, Humana Press, Springer Science Business Media, 2013, pp 335-340.
10.
Ogawa S, Kobayashi H, Amada S, Yahata H, Sonoda K, Abe K, Baba S, Sasaki M, Kaku T, Wake N: Sentinel node detection with 99mTc phytate alone is satisfactory for cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy. Int J Clin Oncol 2010;15:52-58.
11.
Barranger E, Cortez A, Uzan S, Callard P, Darai E: Value of intraoperative imprint cytology of sentinel nodes in patients with cervical cancer. Gynecol Oncol 2004;94:175-180.
12.
Lennox GK, Covens A: Can sentinel lymph node biopsy replace pelvic lymphadenectomy for early cervical cancer? Gynecol Oncol 2017;144:16-20.
13.
See comment in PubMed Commons below Brar H, Hogen L, Covens A: Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer. Cancer 2017;123:1751-1759. https://www.ncbi.nlm.nih.gov/pubmed/?term=Brar+H%2C+sentinel+lymph+node.
14.
Fader AN, Edwards RP, Cost M, Kanbour-Shakir A, Kelley JL, Schwartz B, Sukumvanich P, Comerci J, Sumkin J, Elishaev E, Rohan LC: Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment. Gynecol Oncol 2008;111:13-17.
15.
Di Stefano AB, Acquaviva G, Garozzo G, Barbic M, Cvjeticanin B, Meglic L, Kobal B, Rakar S: Lymph node mapping and sentinel node detection in patients with cervical carcinoma: a 2-year experience. Gynecol Oncol 2005;99:671-679.
16.
Martínez A, Mery E, Filleron T, Boileau L, Ferron G, Querleu D: Accuracy of intraoperative pathological examination of SLN in cervical cancer. Gynecol Oncol 2013;130:525-529.
17.
Daraï E, Lavoué V, Rouzier R, Coutant C, Barranger E, Bats AS: Contribution of the sentinel node procedure to tailoring the radicality of hysterectomy for cervical cancer. Gynecol Oncol 2007;106:251-256.
18.
Wydra D, Sawicki S, Wojtylak S, Bandurski T, Emerich J: Lymph node identification in cervical cancer patients undergoing transperitoneal radical hysterectomy: a study of 100 cases. Int J Gynecol Cancer 2006;16:649-654.
19.
Bats AS, Buénerd A, Querleu D, Leblanc E, Daraï E, Morice P, Marret H, Gillaizeau F, Mathevet P, Lécuru F; SENTICOL Collaborative Group: Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: a prospective, multicenter study. Gynecol Oncol 2011;123:230-235.
20.
Roy M, Bouchard-Fortier G, Popa I, Grégoire J, Renaud MC: Value of sentinel node mapping in cancer of the cervix. Gynecol Oncol 2011;122:269-274.
21.
Slama J, Dundr, P, Dusek L, Cibula D: High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol 2013;129:384-388.
22.
Niikura H, Okamoto S, Otsuki T, Yoshinaga K, Utsunomiya H, Nagase S, Takano T, Ito K, Watanabe M, Yaegashi N: Prospective study of sentinel lymph node biopsy without further pelvic lymphadenectomy in patients with sentinel lymph node-negative cervical cancer. Int J Gynecol Cancer 2012;22:1244-1250.
23.
Gortzak-Uzan L, Jimenez W, Nofech-Mozes S, Ismiil N, Khalifa MA, Dubé V, Rosen B, Murphy J, Laframboise S, Covens A: Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: is it time to change the gold standard? Gynecol Oncol 2010;116:28-32.
24.
Daraï E, Rouzier R, Ballester M, Barranger E, Coutant C: Sentinel lymph node biopsy in gynaecological cancers: the importance of micrometastases in cervical cancer. Surg Oncol 2008;17:227-235.
25.
Diaz JP, Gemignani ML, Pandit-Taskar N, Park KJ, Murray MP, Chi DS, Sonoda Y, Barakat RR, Abu-Rustum NR: Sentinel lymph node biopsy in the management of early-stage cervical carcinoma. Gynecol Oncol 2011;120:347-352.
26.
Cibula D, Abu-Rustum NR, Dusek L, Zikán M, Zaal A, Sevcik L, Kenter GG, Querleu D, Jach R, Bats AS, Dyduch G, Graf P, Klat J, Lacheta J, Meijer CJ, Mery E, Verheijen R, Zweemer RP: Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol 2012;124:496-501.
27.
Zaal A, Zweemer RP, Zikán M, Dusek L, Querleu D, Lécuru F, Bats AS, Jach R, Sevcik L, Graf P, Klát J, Dyduch G, von Mensdorff-Pouilly S, Kenter GG, Verheijen RH, Cibula D: Pelvic lymphadenectomy improves survival in patients with cervical cancer with low-volume disease in the sentinel node: a retrospective multicenter cohort study. Int J Gynecol Cancer 2014;24:303-311.
28.
Colturato LF, Signorini Filho RC, Fernandes RC, Gebrim LH, Oliani AH: Lymph node micrometastases in initial stage cervical cancer and tumoral recurrence. Int J Gynecol Obstet 2016;133:69-75.
29.
Tax C, Rovers MM, de Graaf C, Zusterzeel PL, Bekkers RL: The sentinel node procedure in early stage cervical cancer, taking the next step; a diagnostic review. Gynecol Oncol 2015;139:559-567.
30.
Kato H, Ohba Y, Yamazaki H, Minobe S, Sudo S, Todo Y, Okamoto K: Availability of tissue rinse liquid-based cytology for the rapid diagnosis of sentinel lymph node metastasis and improved bilateral detection by photodynamic eye camera. Jpn J Clin Oncol 2015;45:727-731.
31.
Martinez A, Mery E, Ferron G, Querleu D: Incidence of micrometastases in histologically negative para-aortic lymph nodes in advanced cervical cancer patients. Gynecol Oncol 2010;119:76-80.
32.
Van Trappen PO, Gyselman VG, Lowe DG: Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet 2001;357:15-20.
33.
Okamoto S, Niikura H, Nakabayashi K, Hiyama K, Matoda M, Takeshima N, Watanabe M, Nagase S, Otsuki T, Yaegashi N: Detection of sentinel lymph node metastases in cervical cancer: assessment of KRT19 mRNA in the one-step nucleic acid amplification (OSNA) method. Gynecol Oncol 2013;130:530-536.
34.
Wang HY, Sun JM, Lu HF, Shi DR, Ou ZL, Ren YL, Fu SQ: Micrometastases detected by cytokeratin 19 expression in sentinel lymph nodes of patients with early-stage cervical cancer. Int J Gynecol Cancer 2006;16:643-648.
35.
Popa I, Plante M, Renaud MC, Roy M, Têtu B: Negative sentinel lymph node accurately predicts negative status of pelvic lymph nodes in uterine cervix carcinoma. Gynecol Oncol 2006;103:649-653.
36.
Häfner N, Gajda M, Altgassen C, Hertel H, Greinke C, Hillemanns P, Schneider A, Dürst M: HPV16-E6 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR. Int J Cancer 2007;120:1842-1846.
37.
Lee YS, Rhim CC, Lee HN, Lee KH, Park JS, Namkoong SE: HPV status in sentinel nodes might be a prognostic factor in cervical cancer. Gynecol Oncol 2007;105:351-357.
38.
Köhler C, Le X, Dogan NU, Pfiffer T, Schneider A, Marnitz S, Bertolini J, Favero G: Molecular diagnosis for nodal metastasis in endoscopically managed cervical cancer: the accuracy of the APTIMA test to detect high-risk human papillomavirus messenger RNA in sentinel lymph nodes. J Minim Invasive Gynecol 2016;23:748-752.
39.
Lukaszuk K, Liss J, Wozniak I, Slwiniski W, Emerich J, Wojcikowski C: HPV and histological status of pelvic lymph node metastasis in cervical cancer: a prospective study. J Clin Pathol 2004;57:472-476.
40.
Noventa M, Ancona E, Cosmi E, Saccardi C, Litta P, D'Antona D, Nardelli GB, Gizzo S: Usefulness, methods and rationale of lymph nodes HPV-DNA investigation in estimating risk of early stage cervical cancer recurrence: a systematic literature review. Clin Exp Metastasis 2014;31:853-867.
41.
Tortora M, Annunziata C, Liguori G, Losito S, Botti G, Greggi S, Buonaguro L, Buonaguro FM, Tornesello ML: Detection of human papillomavirus DNA in peri-tumor tissues and pelvic lymph nodes as potential molecular marker of micrometastasis in cervical cancer. Infect Agent Cancer 2016;11:22.
42.
Miccò M, Vargas HA, Burger IA, Kollmeier MA, Goldman DA, Park KJ, Abu-Rustum NR, Hricak H, Sala E: Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Eur J Radiol 2014;83:1169-1176.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.